SILVERBACK THERAPEUTICS INC shareholders Q3 2023

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
Nantahala Capital Management 1,099,075$4,154,5040.36%
Tejara Capital Ltd 103,739$392,1330.22%
TANG CAPITAL MANAGEMENT LLC 409,463$1,547,7700.22%
Brendel Financial Advisors LLC 19,125$720.11%
Rubric Capital Management LP 639,203$2,416,1870.09%
Clearline Capital LP 271,678$1,026,9430.09%
Soleus Capital Management, L.P. 150,000$567,0000.05%
Baker Brothers Advisors 2,006,451$7,584,3850.04%
Woodline Partners LP 847,054$3,201,8640.04%
LEVIN CAPITAL STRATEGIES, L.P. 70,000$264,6000.03%
External links

This page lists SILVERBACK THERAPEUTICS INC's shareholders in Q3 2023. To view SILVERBACK THERAPEUTICS INC's shareholder history, click here.